The nation of Zimbabwe has turned down a major US health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' request for sensitive information.
This move came to light after a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman has since stated that the United States was seeking genetic material for research and commercial purposes but was not willing to share the benefits from future medical innovations.
"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for further talks to reach a deal agreeable to all parties so the country's critical HIV programme can continue.
Broader Context
Zimbabwe's decision follows a comparable situation in Kenya, where a high court halted a similar deal with the US after concerns were filed about the safety of citizens' medical information.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government deals to enhance transparency and responsibility.
According to reports, Sixteen nations in Africa have to date agreed to similar health pacts, representing over $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to share its biological resources and data over an extended period, with no corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our citizens if a new health crisis arise."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting structures previously set up via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This mechanism is designed to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how future collaboration could be arranged in a manner that respects the sovereignty and dignity of each country."
Medical Community Response
Medical experts said it acknowledged the official position, but urged that talks need to persist given that a large portion of the nation's HIV programmes relied on foreign aid.
"If technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it commented.
The situation underscores the ongoing challenges between receiving crucial international aid and safeguarding national sovereignty in an increasingly data-driven world.